Comparative analysis of PD ‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumours using ex vivo IL ‐2 stimulation data
CPT: Pharmacometrics & Systems Pharmacology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要